Epigenetic Drift Alters AID Targeting in Aged B Cells, Shifting Mutations Away from CDRs and Undermining Affinity Maturation
Observation: Aged B cells exhibit deteriorated somatic hypermutation (SHM) quality, with reduced mutation frequencies in key variable genes and lower replacement-to-silent (R:S) ratios in complementarity-determining regions (CDRs) PMC2326838. While decreased expression of activation-induced cytidine deaminase (AID) and E47 contributes PMC7674578, it does not fully explain the shift in mutation patterns.
Hypothesis: We propose that age-related epigenetic drift in B cells alters chromatin accessibility at immunoglobulin variable loci, mistargeting AID away from CDRs and towards framework regions or off-target sites. This results in less effective affinity maturation despite normal overall SHM rates.
Mechanistic Rationale: AID targets single-stranded DNA during transcription, with preference for WRCY motifs. Its targeting is influenced by local chromatin state, histone modifications, and transcription elongation factors. In aging, widespread epigenetic changes occur, including DNA methylation shifts and histone modification alterations. We hypothesize that these changes reduce chromatin accessibility at CDR-encoding segments while increasing accessibility at less critical regions. Consequently, AID-induced mutations accumulate outside CDRs, diminishing the probability of generating high-affinity variants. This mechanism could explain the observed drop in R:S ratios in CDRs PMC2326838 and the failure of pan-B cell depletion to restore antibody responses doi.org/10.1111/acel.12959, as newly generated B cells from an aged bone marrow may inherit these epigenetic defects.
Testable Predictions:
- Germinal center B cells from aged individuals will show altered chromatin accessibility at immunoglobulin variable gene segments compared to young controls, as measured by ATAC-seq or ChIP-seq for histone marks.
- SHM mapping in aged B cells will reveal a higher proportion of mutations outside CDRs, particularly in framework regions, and increased off-target AID activity.
- In vitro, aged B cells activated under identical conditions will exhibit mistargeted AID activity even when AID expression is normalized.
- Epigenetic modulators (e.g., HDAC inhibitors) applied to aged B cells could restore normal AID targeting and improve antibody affinity maturation in germinal center reactions.
Broader Implications: This hypothesis links the well-documented epigenetic changes of aging to the functional decline of adaptive immunity. It suggests that restoring the epigenetic landscape in B cells might rejuvenate antibody quality more effectively than merely expanding B cell numbers. Additionally, it provides a novel explanation for the vicious cycle between poor B cell function and T cell senescence Science Immunology: if B cells present poorly mutated antigens, Tfh help may be inadequate, further impairing selection.